Zevia PBC (NYSE:ZVIA) Receives Average Rating of “Hold” from Analysts

Zevia PBC (NYSE:ZVIA) has been given an average rating of “Hold” by the four research firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $4.50.

A number of research firms have issued reports on ZVIA. Weiss Ratings raised shares of Zevia PBC from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, July 17th. Wall Street Zen cut shares of Zevia PBC from a “hold” rating to a “sell” rating in a report on Saturday, August 8th.

Insiders Place Their Bets

In other Zevia PBC news, major shareholder De Depot Et Placement D. Caisse sold 2,150,000 shares of Zevia PBC stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $1.90, for a total transaction of $4,085,000.00. Following the completion of the transaction, the insider owned 11,400,428 shares in the company, valued at approximately $21,660,813.20. This trade represents a 15.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 7.70% of the company’s stock.

Institutional Trading of Zevia PBC

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Quadrature Capital Ltd purchased a new stake in Zevia PBC in the 4th quarter worth approximately $26,000. Tocqueville Asset Management L.P. acquired a new position in shares of Zevia PBC in the 2nd quarter valued at $26,000. Engineers Gate Manager LP purchased a new stake in Zevia PBC during the fourth quarter worth $28,000. SG Americas Securities LLC acquired a new stake in Zevia PBC during the fourth quarter valued at $31,000. Finally, The Manufacturers Life Insurance Company purchased a new position in Zevia PBC in the fourth quarter valued at $38,000. 53.21% of the stock is owned by institutional investors and hedge funds.

Zevia PBC Price Performance

NYSE ZVIA opened at $1.35 on Thursday. The company has a market cap of $104.31 million, a price-to-earnings ratio of -10.42 and a beta of 0.99. The stock’s fifty day moving average price is $1.56 and its 200 day moving average price is $1.47. Zevia PBC has a 1 year low of $1.11 and a 1 year high of $3.22.

Zevia PBC (NYSE:ZVIA) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($0.03) EPS for the quarter, hitting analysts’ consensus estimates of ($0.03). Zevia PBC had a negative return on equity of 16.92% and a negative net margin of 5.34%.The company had revenue of $45.00 million during the quarter, compared to analysts’ expectations of $44.21 million. Research analysts expect that Zevia PBC will post -0.1 earnings per share for the current year.

About Zevia PBC

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.